PMC:7195088 / 24564-24800 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T120","span":{"begin":64,"end":72},"obj":"Disease"}],"attributes":[{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Comparison of favipiravir vs. standard of care in patients with COVID-19. Open-label RCT (NCT04333589, not yet recruiting). Primary endpoint: viral nucleic acid test negative conversion rate in nasopharyngeal swabs (follow-up 5 months)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T122","span":{"begin":79,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T123","span":{"begin":161,"end":165},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Comparison of favipiravir vs. standard of care in patients with COVID-19. Open-label RCT (NCT04333589, not yet recruiting). Primary endpoint: viral nucleic acid test negative conversion rate in nasopharyngeal swabs (follow-up 5 months)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T313","span":{"begin":14,"end":25},"obj":"Chemical"},{"id":"T314","span":{"begin":79,"end":84},"obj":"Chemical"},{"id":"T315","span":{"begin":148,"end":160},"obj":"Chemical"},{"id":"T316","span":{"begin":156,"end":160},"obj":"Chemical"}],"attributes":[{"id":"A313","pred":"chebi_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A314","pred":"chebi_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A315","pred":"chebi_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A316","pred":"chebi_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"Comparison of favipiravir vs. standard of care in patients with COVID-19. Open-label RCT (NCT04333589, not yet recruiting). Primary endpoint: viral nucleic acid test negative conversion rate in nasopharyngeal swabs (follow-up 5 months)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T184","span":{"begin":74,"end":123},"obj":"Sentence"},{"id":"T185","span":{"begin":124,"end":236},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Comparison of favipiravir vs. standard of care in patients with COVID-19. Open-label RCT (NCT04333589, not yet recruiting). Primary endpoint: viral nucleic acid test negative conversion rate in nasopharyngeal swabs (follow-up 5 months)."}